Rankings
▼
Calendar
ALKS FY 2011 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$390M
+108.9% YoY
Gross Profit
$262M
67.3% margin
Operating Income
-$88M
-22.6% margin
Net Income
-$114M
-29.1% margin
EPS (Diluted)
$-0.99
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$15M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$601M
Stockholders' Equity
$905M
Cash & Equivalents
$85M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$390M
$187M
+108.9%
Gross Profit
$262M
$134M
+95.2%
Operating Income
-$88M
-$46M
-93.5%
Net Income
-$114M
-$46M
-149.6%
← FY 2010
All Quarters
FY 2012 →